Author Archives: Rabita Aziz

Future of global health funding uncertain during time of great need, panelists say

By on .

While lawmakers have indicated they may reject cuts to U.S. global health funding, the Trump Administration’s proposed cuts to the U.S. Agency for International Development and the National Institutes for Health, among other agencies, “should be looked at as a clear direction of where U.S. policy towards global health is going,” Jen Kates of the […]

From bird flu to yellow fever, we’re reading about zoonotic disease outbreaks

By on .

Human cases of bird flu are surging, officials concerned of high pandemic potential – Genetic changes in the H7N9 virus are alarming public health officials globally and are causing officials to reexamine their pandemic preparedness. Over 460 people in China have been infected with the H7N9 bird flu virus this winter, representing one third of […]

Transition 2017: Tillerson confirmed as Secretary of State after divided Senate vote

By on .

The Senate confirmed Rex Tillerson to become Secretary of State on Wednesday after a vote that saw the former chief executive of ExxonMobil receive more opposing votes than any other secretary of state nominee in American history. With a 56-43 vote, three Democrats and one independent joined all 52 Senate Republicans in confirming Tillerson to […]

115th Congress and Global Health: House Energy and Commerce gets new Chair, new leader and members for its Health Subcommittee

By on .

Rep. Greg Walden (R-OR) – Fresh after ensuring the House remained in Republican control after serving as chair of the National Republican Congressional Committee, Rep. Walden takes over as chairman of the House Energy and Commerce Committee from Rep. Fred Upton, who stepped down due to term limits. Before he was elected to the House […]

Yellow fever, Zika, Ebola — We’re reading about outbreaks old and new, and the global response

By on .

Yellow fever outbreak in Brazil – Brazil’s Ministry of Health reports dozens of deaths resulting from a yellow fever outbreak in Minas Gerais, a large, inland state with low yellow fever vaccine coverage. Because Minas Gerais is adjacent to the states of Sao Paolo, Rio de Janeiro and other highly populated states with low vaccine […]

Trump administration should be ready for global infectious disease outbreaks from day one, panel says

By on .

No matter how hard the Trump administration will try to focus solely on domestic issues to “make America great again,” Bill Steiger said last week at an event on pandemic preparedness at Georgetown University, a public health issue of international importance will arise that will demand the U.S. government’s attention. And investing in building up […]

The 115th Congress and Global Health: Senate Appropriations gets new members with range of stances, involvement in disease responses

By on .

Sen. Marco Rubio (R-Florida) – The junior Senator from Florida, Sen. Rubio joined the Senate in 2010, having represented his Miami district in the Florida state legislature from 2000 to 2008. Sen. Rubio will continue to serve on the Senate Foreign Relations Committee for the fourth consecutive Congress and on its Subcommittee on Africa and […]

Congress extends Continuing Resolution adding some funding to NIH, FDA through Cures Act

By on .

Avoiding a government shutdown with just an hour to spare, the U.S. Senate late Friday night passed a continuing resolution to fund the government until April 28, 2017. The House had passed the bill, which maintains most federal programs at current funding levels, on Thursday. Many congressional Democrats argued to extend federal funding for the full […]

IDWeek 2016: Low- and middle-income countries are most affected by antimicrobial resistance, have the least capacity to address it

By on .

NEW ORLEANS, La – Low- and middle income countries have lower per-capita consumption of antibiotics than high income countries yet bear a larger burden of antimicrobial resistance, panelists said at IDWeek. While high-income countries are looking to develop innovative stewardship programs and new drugs to combat antimicrobial resistance, low- and middle-income countries often have limited capacity […]